Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03566888 · ClinicalTrials.gov registry record

Validation of a Noninvasive Automated Blood Pressure Device

A clinical trial, sponsored by University of Southern California.

Completed
Registry status
85
Enrollment target

NCT03566888 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 85 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03566888 has completed, sponsored by University of Southern California.

COMPLETED
Registry status
85 participants
Enrollment target

Study Summary

The investigator's objective is to validate the novel automated blood pressure device against the requirements set forth in the AAMI\_ISO 81060-2:2010 standard in voluntarily consented study participants.

Interventions

  • DEVICE Blood pressure assessment

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2017-08-01
Est. Completion 2018-10-02

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT03566888

The ClinicalTrials.gov registry entry for NCT03566888 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Blood pressure assessment is the first listed.

NCT03566888 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03566888 about?

NCT03566888 is a clinical study titled "Validation of a Noninvasive Automated Blood Pressure Device". The investigator's objective is to validate the novel automated blood pressure device against the requirements set forth in the AAMI\_ISO 81060-2:2010 standard in voluntarily consented study participants.

What is the current status of trial NCT03566888?

This trial is currently completed. The enrollment target is 85 participants. The study started on 2017-08-01. Estimated completion is 2018-10-02.

What interventions are being tested in trial NCT03566888?

The interventions under investigation include: Blood pressure assessment (DEVICE).

Who is sponsoring clinical trial NCT03566888?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.